Medical Research
(H50)
THE INTERNATIONAL THYROID CANCER STUDY GROUP INC
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2023
$380K
Total Revenue
$211K
Total Expenses
N/A
Net Assets
0
Employees
Program Expense Ratio
N/A
Fundraising Efficiency
N/A
Operating Reserve
N/A
Liability-to-Asset
N/A
Revenue Diversification
N/A
Executive Compensation
$0
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $380K | $211K | N/A | — | 0 |
| 2022 | $420K | $168K | N/A | — | 0 |
| 2021 | $371K | $127K | N/A | — | 0 |
Donor Reviews
No reviews yet
Be the first to share your experience with this organization.